Celularity Faces Nasdaq Compliance Warning Over Delayed Financial Filings
Biotechnology company Celularity has received a non-compliance notice from Nasdaq after failing to submit its required quarterly 10-Q financial report on time. The company is now working to rectify the filing delays to maintain its exchange listing status.
The Story
Analyzing sources…
Source Diversity
Source Diversity
Moderate (32/100)Sources
Celularity receives Nasdaq non-compliance notice over delayed 10-Q filings
Read full article →Celularity Provides Update Regarding Nasdaq Listing Compliance - Taiwan News
Celularity Provides Update Regarding Nasdaq Listing Compliance Taiwan News
Read full article →Coverage Timeline
Related Stories

SM Entertainment and Tencent Music Form Joint Venture for New Chinese Idol Group
15m ago
August Consumer and Business Confidence Data Reveals Mixed Regional Trends
15m ago

US-Canada Trade Tensions Drive Up Prices and Spark Canadian Boycotts
30m ago

Bank of Korea Raises Interest Rates to 3 Percent Amid Persistent Inflation
30m ago